Dual Unsafe Injection and Sexual Behaviors for HIV Infection Among People Who Inject Drugs in Iran

Springer Science and Business Media LLC - Tập 23 - Trang 1594-1603 - 2018
Aryan Esmaeili1,2, Mostafa Shokoohi1,3, Ahmad Danesh4, Hamid Sharifi1, Mohammad Karamouzian5,1, AliAkbar Haghdoost1,6, Armita Shahesmaeili1, Samaneh Akbarpour7, Meghan D. Morris2, Ali Mirzazadeh1,2
1HIV/STI Surveillance Research Center and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
2Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, USA
3Epidemiology and Biostatistics, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, Canada
4Golestan Research Center of Psychiatry, Golestan University of Medical Sciences, Gorgan, Iran
5School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, Canada
6Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
7Center for Disease Control (CDC), Ministry of Health and Medical Education, Tehran, Iran

Tóm tắt

We used two national surveys (2010: N = 1597; 2013: N = 1057) of people who inject drugs (PWID) in past-month to assess the prevalence and population size of PWID with either safe or unsafe injection and sex behaviors, overall and by HIV status. In 2013, only 27.0% (vs. 32.3% in 2010) had safe injection and sex, 24.6% (vs. 23.3% in 2010) had unsafe injection and sex, 26.4% (vs. 26.5% in 2010) had only unsafe injection, and 22.0% (vs. 18.0% in 2010) had unsafe sex only. Among HIV-positive PWID in 2013, only 22.1% (~ 2200 persons) had safe injection and sex, 14.2% (~ 1400 persons) had unsafe injection and sex, 53.1% (~ 5200 persons) had unsafe injection, and 10.6% had unsafe sex (~ 1100 persons). Among HIV-negative PWID in 2013, only 27.5% (~ 22,200 persons) had safe injection and sex, 25.9% (~ 20,900 PWID) had unsafe injection and sex, 23.2% (~ 18,700 persons) had unsafe injection, and 23.3% (~ 18,800 persons) had unsafe sex. HIV-positive and -negative PWID in Iran continue to be at risk of HIV acquisition or transmission which calls for targeted preventions services.

Tài liệu tham khảo

Kim NJ, et al. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012. Int J Drug Policy. 2015;26(12):1238–43.

Khajehkazemi R, et al. HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey. Sex Transm Infect. 2013;89(Suppl 3):iii29-32.

National AIDS Committee Secretariat. Islamic Republic of Iran AIDS Progress Report (http://www.unaids.org/sites/default/files/country/documents/IRN_narrative_report_2015.pdf). In: office HS, editor. Tehran: Ministry of Health and Medical Education. 2015.

Nikfarjam A, et al. National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran. Int J Drug Policy. 2016;31:147–52.

Malta M, et al. HIV prevalence among female sex workers, drug users and men who have sex with men in Brazil: a systematic review and meta-analysis. BMC Public Health. 2010;10:317.

Lopez LM, et al. Behavioral interventions for improving condom use for dual protection. Cochrane Database Syst Rev. 2013;10:CD010662.

Malekinejad M, et al. Effectiveness of community-based condom distribution interventions to prevent HIV in the United States: a systematic review and meta-analysis. PLoS ONE. 2017;12(8):e0180718.

Thiede H, et al. Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug Alcohol Depend. 2007;91(Suppl 1):S39–47.

Herbst JH, et al. A meta-analytic review of HIV behavioral interventions for reducing sexual risk behavior of men who have sex with men. J Acquir Immune Defic Syndr. 2005;39(2):228–41.

Huang Q, et al. Prevalence of HIV infection and syphilis, sexual behaviors and awareness of HIV/AIDS related knowledge among men who have sex with men in China: a Meta-analysis of data collected from 2010 to 2013. Zhonghua Liu Xing Bing Xue Za Zhi. 2015;36(11):1297–304.

Chow EP, et al. Behavioral interventions improve condom use and HIV testing uptake among female sex workers in China: a systematic review and meta-analysis. AIDS Patient Care STDS. 2015;29(8):454–60.

Copenhaver MM, et al. Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy. J Subst Abuse Treat. 2006;31(2):163–71.

Amin-Esmaeili M, et al. Profile of people who inject drugs in Tehran, Iran. Acta Med Iran. 2016;54(12):793–805.

Arruda MM, et al. Sensitivity and specificity of parallel or serial serological testing for detection of canine Leishmania infection. Mem Inst Oswaldo Cruz. 2016;111(3):168–73.

Treloar C, Wilson H, Mao L. Deconstructing injecting risk of hepatitis C virus transmission: using strategic positioning to understand “higher risk” practices. Drugs: Education, Prevention and Policy. 2016;23(6):457–61.

Ministry of Health and Medical Education. AIDS Progress Report on Monitoring of the United Nations General Assembly Special Session on HIV and AIDS (https://goo.gl/7xeeVZ). Tehran: National AIDS Committee Secretariat, Ministry of Health and Medical Education, Islamic Republic of Iran.; March 2015.

Shokoohi M, et al. Low HIV testing rate and its correlates among men who inject drugs in Iran. Int J Drug Policy. 2016;32:64–9.

Kennedy CE, et al. Behavioural interventions for HIV positive prevention in developing countries: a systematic review and meta-analysis. Bull World Health Organ. 2010;88(8):615–23.

Noroozi A, et al. Impact of HIV status notification on risk behaviors among men who inject drugs in Kermanshah, West of Iran. J Res Health Sci. 2016;16(3):116–21.

Radfar SR, et al. Behaviors influencing human immunodeficiency virus transmission in the context of positive prevention among people living with HIV/acquired immunodeficiency syndrome in Iran: a qualitative study. Int J Prev Med. 2014;5(8):976–83.

Radfar SR, Nematollahi P, Arasteh M. Factors influencing access and use of care and treatment services among iranian people living with HIV and AIDS: a qualitative study. Iran J Public Health. 2016;45(1):109–11.

Mgbere O, et al. System and patient barriers to care among people living with HIV/AIDS in Houston/Harris County, Texas: HIV Medical Care Providers’ Perspectives. J Int Assoc Provid AIDS Care. 2015;14(6):505–15.

Noroozi M, et al. Injecting and sexual networks and sociodemographic factors and dual HIV risk among people who inject drugs: a cross-sectional study in Kermanshah Province, Iran. Addict Health. 2016;8(3):186–94.

Rahimi-Movaghar A, et al. HIV prevalence amongst injecting drug users in Iran: a systematic review of studies conducted during the decade 1998-2007. Int J Drug Policy. 2012;23(4):271–8.

Nasirian M, et al. Modeling of human immunodeficiency virus modes of transmission in Iran. J Res Health Sci. 2012;12(2):81–7.

Guise A, Albers ER, Strathdee SA. ‘PrEP is not ready for our community, and our community is not ready for PrEP’: pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response. Addiction. 2017;112(4):572–8.

Bernard CL, et al. Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: a model-based analysis. PLoS Med. 2017;14(5):e1002312.

Fu R, Owens DK, Brandeau ML. Cost-effectiveness of alternative strategies for provision of HIV pre-exposure prophylaxis for people who inject drugs. AIDS. 2018;32(5):663–72.

Alipour A, et al. HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010. Sex Transm Infect. 2013;89(Suppl 3):iii41-4.

Bandali S. Norms and practices within marriage which shape gender roles, HIV/AIDS risk and risk reduction strategies in Cabo Delgado, Mozambique. AIDS Care. 2011;23(9):1171–6.

Mtenga SM, et al. ‘It is not expected for married couples’: a qualitative study on challenges to safer sex communication among polygamous and monogamous partners in southeastern Tanzania. Glob Health Action. 2016;9:323–6.

Pinchoff J, et al. Why don’t urban youth in Zambia use condoms? The influence of gender and marriage on non-use of male condoms among young adults. PLoS ONE. 2017;12(3):e0172062.

Maia C, Guilhem D, Freitas D. Vulnerability to HIV/AIDS in married heterosexual people or people in a common-law marriage. Rev Saude Publica. 2008;42(2):242–8.

Raymond E, Trussell J. Condom use within marriage: a neglected HIV intervention. Bull World Health Organ. 2005;83(3):239.

Wand H, et al. Individual and population level impacts of illicit drug use, sexual risk behaviours on sexually transmitted infections among young Aboriginal and Torres Strait Islander people: results from the GOANNA survey. BMC Public Health. 2016;16:600.

Hoenigl M, et al. Clear links between starting methamphetamine and increasing sexual risk behavior: a cohort study among men who have sex with men. J Acquir Immune Defic Syndr. 2016;71(5):551–7.

Shoptaw S, Reback CJ. Methamphetamine use and infectious disease-related behaviors in men who have sex with men: implications for interventions. Addiction. 2007;102(Suppl 1):130–5.

Noroozi A, Malekinejad M, Rahimi-Movaghar A. Factors influencing transition to Shisheh (Methamphetamine) among young people who use drugs in Tehran: a qualitative study. J Psychoactive Drugs. 2018;50(3):214–23.

Rahimi-Movaghar A, et al. Use of stimulant substances among university students in tehran: a qualitative study. Iran J Psychiatry Behav Sci. 2011;5(2):32–42.

Fallah G, et al. Stimulant use in medical students and residents requires more careful attention. Caspian J Intern Med. 2018;9(1):87–91.

Alam-Mehrjerdi Z, Abdollahi M. The Persian methamphetamine use in methadone treatment in Iran: implication for prevention and treatment in an upper-middle income country. Daru. 2015;23:51.

Shariatirad S, Maarefvand M, Ekhtiari H. Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran. Int J Drug Policy. 2013;24(6):e115–6.

Hurtado Navarro I, et al. Differences between women and men in serial HIV prevalence and incidence trends. Eur J Epidemiol. 2008;23(6):435–40.

Viitanen P, et al. Hepatitis A, B, C and HIV infections among finnish female prisoners—young females a risk group. J Infect. 2011;62(1):59–66.

Tracy D, et al. Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort. BMJ Open. 2014;4(5):e004988.

Montgomery SB, et al. Gender differences in HIV risk behaviors among young injectors and their social network members. Am J Drug Alcohol Abuse. 2002;28(3):453–75.

Des Jarlais DC, et al. Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. Drug Alcohol Depend. 2012;124(1–2):95–107.

Jin H, et al. Differences in HIV risk behaviors among people who inject drugs by gender and sexual orientation, San Francisco, 2012. Drug Alcohol Depend. 2014;145:180–4.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 23

1594-1603

Thông tin tác giả